Novo Nordisk: The Real Comeback Starts Now With The Wegovy Pill [Seeking Alpha]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Seeking Alpha
NVO trades close to a 10-year low forward EBITDA multiple of 10.5x, reflecting deep market pessimism despite recent positive momentum. Intense competition with LLY and pricing pressures persist, but NVO's first-mover advantage in oral obesity drugs could catalyze a much-needed turnaround. Maintaining a Buy rating, as I expect NVO's improved execution and valuation gap with LLY to potentially drive outperformance through 2026. hapabapa/iStock Editorial via Getty Images Novo Nordisk: Has The Revival Started With The Wegovy Pill? A timely "intervention"... this time from the FDA, as Novo Nordisk A/S ( NVO NONOF ) looks to arrest the decline that saw More on my IG service A Growth Investing Service To Help You Outperform I'm a firm believer in growth and tech plays as a core component of our portfolio. Our service has made several top and bottom calls, helping our subscribers to outperform the market consistently. I focus on helping members tune out the noise from the
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Omeros: Stock Pops On Yartemlea Approval, Longer-Term Upside Likely [Seeking Alpha]Seeking Alpha
- FDA approves Novo Nordisk's weight-loss pill [FOX Business Network]FOX Business Network
- Obesity Medicine Association Releases Position Statement: A New Era for Medicare & Medicaid Obesity Medication Coverage [Yahoo! Finance]Yahoo! Finance
- 5 Things to know for Dec. 24: Epstein files, National Guard, Nursing home explosion, Student loans, Weight loss drugs [CNN]CNN
- 5 Things to know for Dec. 24: Epstein files, National Guard, Nursing home explosion, Student loans, Weight loss drugs [CNN]CNN
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website